Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
101.40 x 1 101.94 x 1
Pre-market by (Cboe BZX)
100.69 -0.82 (-0.81%) 03/21/25 [NYSE]
101.40 x 1 101.94 x 1
Pre-market 101.41 +0.72 (+0.72%) 08:50 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
101.41
Day High
101.41
Open 101.41
Previous Close 100.69 100.69
Volume 1,132 1,132
Avg Vol 8,556,707 8,556,707
Stochastic %K 65.71% 65.71%
Weighted Alpha +46.53 +46.53
5-Day Change +2.51 (+2.54%) +2.51 (+2.54%)
52-Week Range 66.80 - 107.17 66.80 - 107.17
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 148,927,552
  • Shares Outstanding, K 1,479,070
  • Annual Sales, $ 16,747 M
  • Annual Income, $ 1,854 M
  • EBIT $ 3,461 M
  • EBITDA $ 5,116 M
  • 60-Month Beta 0.77
  • Price/Sales 8.97
  • Price/Cash Flow 27.81
  • Price/Book 6.80

Options Overview Details

View History
  • Implied Volatility 26.63% ( +0.62%)
  • Historical Volatility 27.06%
  • IV Percentile 84%
  • IV Rank 51.32%
  • IV High 37.97% on 03/11/25
  • IV Low 14.68% on 08/13/24
  • Put/Call Vol Ratio 1.91
  • Today's Volume 13,407
  • Volume Avg (30-Day) 10,754
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 234,277
  • Open Int (30-Day) 208,173

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.67
  • Number of Estimates 10
  • High Estimate 0.68
  • Low Estimate 0.66
  • Prior Year 0.56
  • Growth Rate Est. (year over year) +19.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.29 +8.70%
on 03/10/25
Period Open: 104.39
105.57 -3.94%
on 03/03/25
-2.98 (-2.85%)
since 02/24/25
3-Month
88.81 +14.19%
on 01/02/25
Period Open: 91.07
107.17 -5.37%
on 02/05/25
+10.34 (+11.35%)
since 12/24/24
52-Week
66.80 +51.81%
on 04/22/24
Period Open: 67.62
107.17 -5.37%
on 02/05/25
+33.79 (+49.97%)
since 03/22/24

Most Recent Stories

More News
DGX Stock Set to Benefit From New Google Cloud Partnership

Quest Diagnostics Inc. DGX recently announced a collaboration with Google Cloud, owned by the parent holding company, Alphabet GOOGL. The partnership aims to streamline Quest Diagnostics’ data management,...

GOOGL : 166.69 (+1.65%)
DGX : 167.11 (+0.39%)
BSX : 101.41 (+0.72%)
PODD : 268.32 (+1.10%)
GEHC Stock Gains Following Cardiology Solutions Portfolio Expansion

GE HealthCare Technologies Inc. GEHC, on Monday, announced the launch of the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab. The AltiX AI.i edition are expected to enhance efficiency and precision...

BSX : 101.41 (+0.72%)
COR : 267.43 (-0.15%)
GEHC : 82.14 (+0.80%)
CAH : 131.83 (-0.05%)
GEHC Stock Gains in Pre-Market Following Tie-Up Expansion With NVIDIA

GE HealthCare Technologies Inc. GEHC announced an expansion of its collaboration with NVIDIA Corporation NVDA yesterday. The latest partnership expansion aims to advance AI-driven autonomous solutions...

NVDA : 120.06 (+2.01%)
BSX : 101.41 (+0.72%)
GEHC : 82.14 (+0.80%)
CAH : 131.83 (-0.05%)
Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment

Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment

COO : 81.71 (+1.64%)
ABT : 126.37 (+0.02%)
SYK : 372.00 (+0.24%)
BSX : 101.41 (+0.72%)
NEOG : 8.85 (-1.34%)
2 Reasons to Like BSX (and 1 Not So Much)

2 Reasons to Like BSX (and 1 Not So Much)

BSX : 101.41 (+0.72%)
VEEV Stock Gains Following Latest Availability of HCP Access Data

Veeva Systems Inc. VEEV, on Tuesday, announced Veeva CRM Pulse. It is a data subscription that provides quarterly healthcare professional (HCP) access and multichannel engagement metrics for the life sciences...

BSX : 101.41 (+0.72%)
RMD : 221.21 (+0.69%)
VEEV : 239.57 (+1.18%)
CAH : 131.83 (-0.05%)
FMS Stock Gains Following Stake Sale to Reduce Debt & Boost Profit

Fresenius Medical Care’s FMS parent company Fresenius SE raised nearly €1.1 billion ($1.2 billion) through a strategic sale of shares in Fresenius Medical Care AG and the issuance of exchangeable bonds...

BSX : 101.41 (+0.72%)
MASI : 165.82 (-2.17%)
CAH : 131.83 (-0.05%)
FMS : 24.35 (+0.37%)
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq

Baxter International Inc. BAX recently introduced Voalte Linq , a lightweight, wearable badge powered by Scotty assistant, a voice-activated technology, at the 2025 HIMSS Global Healthcare Conference....

BSX : 101.41 (+0.72%)
BAX : 33.41 (+0.66%)
MASI : 165.82 (-2.17%)
CAH : 131.83 (-0.05%)
Should Labcorp Stock Stay in Your Portfolio Right Now?

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities....

BSX : 101.41 (+0.72%)
MASI : 165.82 (-2.17%)
CAH : 131.83 (-0.05%)
LH : 234.21 (-0.67%)
Is Stryker Stock Outperforming the S&P 500?

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

SYK : 372.00 (+0.24%)
$SPX : 5,667.56 (+0.08%)
BSX : 101.41 (+0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 103.06
2nd Resistance Point 102.03
1st Resistance Point 101.36
Last Price 101.41
1st Support Level 99.66
2nd Support Level 98.63
3rd Support Level 97.96

See More

52-Week High 107.17
Last Price 101.41
Fibonacci 61.8% 91.75
Fibonacci 50% 86.99
Fibonacci 38.2% 82.22
52-Week Low 66.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals